InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Tuesday, 09/01/2015 11:35:15 AM

Tuesday, September 01, 2015 11:35:15 AM

Post# of 345997
If, as many expect, the Sunrise trial produces data similar to the virtually identical Phase II trial, what then? How does Peregrine management proceed? The assumption at that point would be fairly rapid FDA approval.

Based on what they have said for years, management would seek to partner ex-US and retain US rights. The obvious two questions:

Who would be an ideal ex-US partner?

How would they go forward in the US? Is there a likely partner who could handle sales and distribution in the US?

The struggle to get to this point has been rough, but once Peregrine turns this corner the real fun will begin. I am very ready to enter this next phase.

GLTA, Especially the Bavi-arm Sunrise Patients,

Paul

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News